Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (1231)	11/6/1998 6:21:00 PM
From: Bald Man from Mars	Read Replies (4) \| Respond to of 3576

Everyone please jump in until you see 24, I need to break even ... thanks in advance ...

To: Anthony@Pacific who wrote (1231)	11/6/1998 6:25:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 3576

Anthony, When you have a company that cannot earn any money. Let me respond to this from the perspective of a biotech investor rather than the day traders that have overrun this thread. I think there is some element of truth to what you say, but I feel you have gone overboard in condemning the stock. First, I should say that I exited from my own small GERN holding today at 19 7/8. I bought it a while back, when no-one was paying any attention to the stock, which is the right time to buy publicity-prone stocks like GERN and ENMD. However, I disagree that GERN has dismal prospects. While they are certainly a long way from producing anything like a product, they certainly could strike large deals in the short term with any number of big pharmas, and may well develop a nice business selling their cells in the medium term. GERN, like ENMD (which I also own a little of, having recently re-entered in the low 20's after selling near the open on "that day"), is certainly not a sure thing, but they both have striking technology that could well emerge into something major. Even though neither have earnings, neither are they no-brainer shorts. Peter